Margo Adams Larsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Margo Adams Larsen has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Kathryn Elizabeth Muessig
Institute On Digital Health and Innovation, College of Nursing, Florida State University, Tallahassee, USA
6 shared publications - Lisa Hightow-Weidman
College of Nursing, Florida State University, Tallahassee, USA
6 shared publications - Henna Budhwani
Florida State University, Tallahassee, FL, USA
5 shared publications - Marie C. D. Stoner
RTI International, Research Triangle Park, USA
5 shared publications - Allysha C. Maragh-Bass
Global Health and Population Division, FHI 360, Durham, NC 27701, USA
4 shared publications - Maria Leonora G. Comello
University of North Carolina at Chapel Hill
4 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Measuring Content Engagement and Associated Outcomes in a Digital Health Vaccine Intervention for Black Young Adults: A Paradata Analysis (Preprint)
BACKGROUND Digital health interventions (DHIs) hold promise for improving health outcomes. Tough Talks COVID-19 (TT-C) was a culturally tailored, community-informed DHI designed to support Black young adults (YAs) in the US South in making informed COVID-19 vaccination decisions. OBJECTIVE To understand how user engagement, captured through paradata, was associated with improved vaccine attitudes in the TT-C DHI. METHODS We analyzed paradata from 299 Black YAs in Alabama, Georgia, and North Carolina who used the TT-C DHI in a randomized controlled trial. The DHI included 62 self-paced activities that were analyzed using rapid content analysis to identify the specific vaccine uptake-related domain they covered (hesitancy, confidence, conspiracy beliefs, and knowledge). Intervention engagement was defined as number of activities and time spent in the DHI. We used regression models to evaluate associations between intervention engagement and changes in vaccine-related measures after three months of use. RESULTS Overall engagement with the DHI was high.. Greater engagement with the DHI, both in total time and number of activities completed, was associated with larger improvements for all four vaccine outcomes at three months after download (P < 0.05). The effects of the TT-C DHI were amplified when participants engaged in activities that were directly related to the domain of interest, particularly with conspiracy beliefs, which had an effect size three times larger for domain-specific engagement (β: -0.067 [95% CI: -0.130, -0.005]) compared to domain-agnostic engagement (β: -0.019 [95% CI: -0.035, -0.002]) CONCLUSIONS Our findings underscore the value of using paradata to assess DHI effectiveness and highlight that the type of content engaged with is associated with change. These insights can guide future DHI design and real-time adaptive interventions to maximize impact. CLINICALTRIAL ClinicalTrials.gov NCT05490329; https://clinicaltrials.gov/study/NCT05490329
- 3 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMeasuring Content Engagement and Associated Outcomes in a Digital Health Vaccine Intervention for Black Young Adults: A Paradata Analysis (Preprint)
BACKGROUND Digital health interventions (DHIs) hold promise for improving health outcomes. Tough Talks COVID-19 (TT-C) was a culturally tailored, community-informed DHI designed to support Black young adults (YAs) in the US South in making informed COVID-19 vaccination decisions. OBJECTIVE To understand how user engagement, captured through paradata, was associated with improved vaccine attitudes in the TT-C DHI. METHODS We analyzed paradata from 299 Black YAs in Alabama, Georgia, and North Carolina who used the TT-C DHI in a randomized controlled trial. The DHI included 62 self-paced activities that were analyzed using rapid content analysis to identify the specific vaccine uptake-related domain they covered (hesitancy, confidence, conspiracy beliefs, and knowledge). Intervention engagement was defined as number of activities and time spent in the DHI. We used regression models to evaluate associations between intervention engagement and changes in vaccine-related measures after three months of use. RESULTS Overall engagement with the DHI was high.. Greater engagement with the DHI, both in total time and number of activities completed, was associated with larger improvements for all four vaccine outcomes at three months after download (P < 0.05). The effects of the TT-C DHI were amplified when participants engaged in activities that were directly related to the domain of interest, particularly with conspiracy beliefs, which had an effect size three times larger for domain-specific engagement (β: -0.067 [95% CI: -0.130, -0.005]) compared to domain-agnostic engagement (β: -0.019 [95% CI: -0.035, -0.002]) CONCLUSIONS Our findings underscore the value of using paradata to assess DHI effectiveness and highlight that the type of content engaged with is associated with change. These insights can guide future DHI design and real-time adaptive interventions to maximize impact. CLINICALTRIAL ClinicalTrials.gov NCT05490329; https://clinicaltrials.gov/study/NCT05490329
- Open Access
- 21 May 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12, e80087
Enhancing Therapist Training in the Delivery of Exposure Therapy for Individuals with Anxiety Disorders Using Virtual Reality Simulation: Randomized Feasibility Trial
Background: Exposure-based cognitive behavioral therapy is among the least used evidence-based practices for anxiety disorders in routine care. Providers’ negative beliefs about exposure (eg, fears of harm or intolerability) are a major barrier. Experiential methods can reduce these beliefs but are limited by accessibility, standardization, and fidelity. Virtual reality (VR) offers a scalable way to deliver standardized experiential practice. Guided by an “exposure to exposure” (E2E) framework, we conceptualized VR training as an exposure intervention targeting therapists’ own anxious beliefs about exposure. Objective: This feasibility study examined a VR-based exposure training program (SET-VR ) (1) to evaluate usability and effects on therapist learning targets (knowledge, self-efficacy, attitudes) and (2) to test whether a high-immersion head-mounted display (HMD) format provides added benefit over a lower-immersion desktop format. Eligibility included holding an active caseload. Methods: Eligible clinicians (ie, aged >21 years with an active caseload; n=41) completed a 4-hour didactic workshop on exposure and were randomized (1:1, blinded) to the desktop or HMD condition. In the experiential phase, therapists delivered 3 rounds of exposure with a virtual patient. They titrated exposure intensity (increase, decrease, continue as is) at fixed decision points based on state-dependent visual (character animations) and auditory (prerecorded verbalizations) cues reflecting the patient’s distress. Exposure knowledge, self-efficacy, and beliefs about exposure were measured at baseline, post-didactic, post-experiential, and follow-up. Participants also rated the acceptability, usability, and authenticity of the program. Results: Both groups (desktop and HMD) showed significant improvement in exposure knowledge ( d =0.52, P =.006; d =0.58, P =.002), self-efficacy ( d =0.88, P <.001; d =1.36, P <.001), and beliefs ( d =0.61, P =.001; d =1.05, P <.001) from baseline to post-didactic training using binomial generalized estimating equations. There were no significant differences between the low- and high-immersion groups on any measure after didactics. Both groups demonstrated significant improvement in exposure self-efficacy ( d =0.66, P <.001; d =0.93, P <.001) and beliefs ( d =0.46, P <.01; d =0.66, P <.001) from post-didactic to post-experiential. Both groups gave positive ratings for acceptability, usability, and authenticity. No adverse events or side effects were reported. Conclusions: In this feasibility randomized controlled trial, an E2E-guided VR training program produced promising improvements in therapists’ self-efficacy and negative beliefs about exposure beyond gains from didactic training alone. This work is innovative in testing immersion as a dose parameter while also applying an explicit framework (E2E) to target a key mechanism (ie, therapist beliefs) in the underuse of exposure therapy. Compared to prior VR training studies focused on skills and knowledge acquisition, our findings support the standardization of an emotionally engaging exposure practice context that shifts therapist-level mechanisms linked to actual delivery. The lack of clear advantages for HMD over desktop VR suggests that lower-immersion, more scalable implementations may provide a sufficient experiential “dose.” Larger, more diverse trials are needed to confirm effectiveness and determine the real-world impact of VR-based exposure training on access to evidence-based care.
- 21 May 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12, e80087
Open AccessEnhancing Therapist Training in the Delivery of Exposure Therapy for Individuals with Anxiety Disorders Using Virtual Reality Simulation: Randomized Feasibility Trial
Background: Exposure-based cognitive behavioral therapy is among the least used evidence-based practices for anxiety disorders in routine care. Providers’ negative beliefs about exposure (eg, fears of harm or intolerability) are a major barrier. Experiential methods can reduce these beliefs but are limited by accessibility, standardization, and fidelity. Virtual reality (VR) offers a scalable way to deliver standardized experiential practice. Guided by an “exposure to exposure” (E2E) framework, we conceptualized VR training as an exposure intervention targeting therapists’ own anxious beliefs about exposure. Objective: This feasibility study examined a VR-based exposure training program (SET-VR ) (1) to evaluate usability and effects on therapist learning targets (knowledge, self-efficacy, attitudes) and (2) to test whether a high-immersion head-mounted display (HMD) format provides added benefit over a lower-immersion desktop format. Eligibility included holding an active caseload. Methods: Eligible clinicians (ie, aged >21 years with an active caseload; n=41) completed a 4-hour didactic workshop on exposure and were randomized (1:1, blinded) to the desktop or HMD condition. In the experiential phase, therapists delivered 3 rounds of exposure with a virtual patient. They titrated exposure intensity (increase, decrease, continue as is) at fixed decision points based on state-dependent visual (character animations) and auditory (prerecorded verbalizations) cues reflecting the patient’s distress. Exposure knowledge, self-efficacy, and beliefs about exposure were measured at baseline, post-didactic, post-experiential, and follow-up. Participants also rated the acceptability, usability, and authenticity of the program. Results: Both groups (desktop and HMD) showed significant improvement in exposure knowledge ( d =0.52, P =.006; d =0.58, P =.002), self-efficacy ( d =0.88, P <.001; d =1.36, P <.001), and beliefs ( d =0.61, P =.001; d =1.05, P <.001) from baseline to post-didactic training using binomial generalized estimating equations. There were no significant differences between the low- and high-immersion groups on any measure after didactics. Both groups demonstrated significant improvement in exposure self-efficacy ( d =0.66, P <.001; d =0.93, P <.001) and beliefs ( d =0.46, P <.01; d =0.66, P <.001) from post-didactic to post-experiential. Both groups gave positive ratings for acceptability, usability, and authenticity. No adverse events or side effects were reported. Conclusions: In this feasibility randomized controlled trial, an E2E-guided VR training program produced promising improvements in therapists’ self-efficacy and negative beliefs about exposure beyond gains from didactic training alone. This work is innovative in testing immersion as a dose parameter while also applying an explicit framework (E2E) to target a key mechanism (ie, therapist beliefs) in the underuse of exposure therapy. Compared to prior VR training studies focused on skills and knowledge acquisition, our findings support the standardization of an emotionally engaging exposure practice context that shifts therapist-level mechanisms linked to actual delivery. The lack of clear advantages for HMD over desktop VR suggests that lower-immersion, more scalable implementations may provide a sufficient experiential “dose.” Larger, more diverse trials are needed to confirm effectiveness and determine the real-world impact of VR-based exposure training on access to evidence-based care.
- Open Access
- 3 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Enhancing Exposure Therapy Training through Virtual Reality Simulation: A Randomized Pilot Trial (Preprint)
BACKGROUND Despite robust empirical support, exposure-based CBT remains one of the least utilized evidence-based practices (EBPs) for anxiety disorders in typical practice settings. Research suggests providers’ negative beliefs about the risk of negative events during exposure delivery are a major predictor of its underutilization. Studies have demonstrated that incorporating experiential learning such as role-playing into conventional didactic training can reduce therapists’ negative beliefs. However, these methods face limitations in terms of accessibility, standardization, and fidelity to real-life experiences. Emerging evidence suggests virtual reality (VR) simulations may be an effective and scalable alternative for improving skills and attitudes pertinent to mental health treatment. OBJECTIVE This study examines the initial efficacy of a novel VR simulation-based exposure training program (SET-VRTM) based on (1) perceptions of usability, and (2) degree of change in therapist learning targets (i.e. knowledge, self-efficacy, attitudes). Clinician participants were randomly assigned to a low-immersion desktop version or a high-immersion head-mounted display (HMD) version of the SET-VRTM program to explore the influence of immersion on key outcomes. METHODS Clinician participants (N=41) were recruited from a variety of practice settings. Before randomization, both groups received conventional (4-hour) didactic training for exposure therapy. Next, groups were assigned to immersion modality (desktop or HMD) and began delivering exposures to a virtually simulated patient. Participants practiced titrating exposure intensity (increase, decrease, continue) based on real-time visual and auditory cues from the virtual patient. Participants completed three rounds of exposure delivery to a simulated patient and reviewed their decisions with feedback at the end of each round. Exposure knowledge, exposure self-efficacy, and beliefs about exposures were measured at baseline, post-didactic, and post-VR. Participants also rated the acceptability, usability, and real-world authenticity of VR exposure training. RESULTS Both groups (desktop, HMD) showed significant improvement in exposure knowledge (p<.01; p<.01), self-efficacy (p<.01; p<.01), and beliefs about exposure (p<.01; p<.01) between baseline and didactic training. There were no significant differences between the low and high immersion groups on any measure at baseline or after didactics. Both groups demonstrated significant improvement in exposure self-efficacy (p<.01; p<.01) and beliefs (P<.001; p=.012) from post-didactic to post-exposure delivery. Neither showed improved knowledge from post-didactic to post-exposure delivery (p>.05; p>.05). Both groups gave highly positive ratings for the acceptability, usability, and authenticity of the simulated training experience. Taken together, results indicate that VR training significantly improved therapists’ self-efficacy and beliefs about exposures beyond gains from didactic training alone. CONCLUSIONS VR exposure therapy training is both well-received and effective in addressing clinician-level barriers to optimal exposure delivery. Supplementing conventional didactic training with experiential learning via VR sessions may be a promising next step in optimizing the standardization, scalability, and effectiveness of exposure training. CLINICALTRIAL Clinicaltrials.gov Identifier: NCT06706245
- 3 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEnhancing Exposure Therapy Training through Virtual Reality Simulation: A Randomized Pilot Trial (Preprint)
BACKGROUND Despite robust empirical support, exposure-based CBT remains one of the least utilized evidence-based practices (EBPs) for anxiety disorders in typical practice settings. Research suggests providers’ negative beliefs about the risk of negative events during exposure delivery are a major predictor of its underutilization. Studies have demonstrated that incorporating experiential learning such as role-playing into conventional didactic training can reduce therapists’ negative beliefs. However, these methods face limitations in terms of accessibility, standardization, and fidelity to real-life experiences. Emerging evidence suggests virtual reality (VR) simulations may be an effective and scalable alternative for improving skills and attitudes pertinent to mental health treatment. OBJECTIVE This study examines the initial efficacy of a novel VR simulation-based exposure training program (SET-VRTM) based on (1) perceptions of usability, and (2) degree of change in therapist learning targets (i.e. knowledge, self-efficacy, attitudes). Clinician participants were randomly assigned to a low-immersion desktop version or a high-immersion head-mounted display (HMD) version of the SET-VRTM program to explore the influence of immersion on key outcomes. METHODS Clinician participants (N=41) were recruited from a variety of practice settings. Before randomization, both groups received conventional (4-hour) didactic training for exposure therapy. Next, groups were assigned to immersion modality (desktop or HMD) and began delivering exposures to a virtually simulated patient. Participants practiced titrating exposure intensity (increase, decrease, continue) based on real-time visual and auditory cues from the virtual patient. Participants completed three rounds of exposure delivery to a simulated patient and reviewed their decisions with feedback at the end of each round. Exposure knowledge, exposure self-efficacy, and beliefs about exposures were measured at baseline, post-didactic, and post-VR. Participants also rated the acceptability, usability, and real-world authenticity of VR exposure training. RESULTS Both groups (desktop, HMD) showed significant improvement in exposure knowledge (p<.01; p<.01), self-efficacy (p<.01; p<.01), and beliefs about exposure (p<.01; p<.01) between baseline and didactic training. There were no significant differences between the low and high immersion groups on any measure at baseline or after didactics. Both groups demonstrated significant improvement in exposure self-efficacy (p<.01; p<.01) and beliefs (P<.001; p=.012) from post-didactic to post-exposure delivery. Neither showed improved knowledge from post-didactic to post-exposure delivery (p>.05; p>.05). Both groups gave highly positive ratings for the acceptability, usability, and authenticity of the simulated training experience. Taken together, results indicate that VR training significantly improved therapists’ self-efficacy and beliefs about exposures beyond gains from didactic training alone. CONCLUSIONS VR exposure therapy training is both well-received and effective in addressing clinician-level barriers to optimal exposure delivery. Supplementing conventional didactic training with experiential learning via VR sessions may be a promising next step in optimizing the standardization, scalability, and effectiveness of exposure training. CLINICALTRIAL Clinicaltrials.gov Identifier: NCT06706245
- Open Access
- 16 April 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e67370
Greater Improvements in Vaccination Outcomes Among Black Young Adults With Vaccine-Resistant Attitudes in the United States South Following a Digital Health Intervention: Latent Profile Analysis of a Randomized Control Trial
Background: Negative attitudes toward vaccines and suboptimal vaccination rates among African American and Black (Black) Americans have been well documented, due to a history of medical racism and human rights violations in the United States. However, digital health interventions (DHI) have been shown to address racial disparities in several health outcomes, such as cardiovascular disease, HIV, and maternal health. The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults in the United States South to make informed, autonomous decisions about COVID-19 vaccine uptake by addressing structural barriers and misinformation about vaccines. Objective: Our objective was to identify subgroups of Black young adults with various vaccine attitudes at baseline and determine the subgroups for which the TT-C DHI was most impactful. Methods: Black young adults aged 18‐29 years in Alabama, Georgia, and North Carolina who were unvaccinated or insufficiently vaccinated against COVID-19 completed three online surveys over three months (N=360). Latent profile analysis was used to identify subgroups based on general vaccine attitudes at baseline, including hesitancy, confidence, knowledge, conspiracy beliefs, and mistrust. Logistic regression was used to examine the associations between latent profiles and vaccine uptake, and linear regression was used to examine changes in vaccine attitudes at three months post-randomization. Modification of the TT-C DHI’s effects was assessed by latent profiles. Results: Three latent profiles emerged: vaccine-receptive (n=124), vaccine-neutral (n=155), and vaccine-resistant (n=81). Political affiliation, income, social support, and recent flu vaccination differed significantly between the three subgroups (P<.05). Vaccine uptake was not significantly different by subgroup, and the TTC-DHI did not have differing effects on uptake across subgroups. However, the DHI had the strongest effect—with statistically significant measures of association (P<.05) and interaction P values (P<.10)—among the baseline vaccine-resistant and vaccine-neutral subgroups compared to the vaccine-receptive subgroups at three months in improving vaccine hesitancy, confidence, and conspiracy beliefs at three months: vaccine-resistant difference: −0.40 (−0.76 to −0.37), 0.39 (0.02 to 0.75), and −0.47 (−0.86 to −0.09); vaccine neutral difference: −0.36 (−0.52 to −0.19), 0.35 (0.18 to 0.51), and −0.24 (−0.44 to −0.03). The DHI had no effects on these outcomes among the vaccine-receptive subgroup. Conclusions: Our findings revealed subgroups of Black young adults in the United States South with different vaccination attitudes, for which the TT-C intervention had differing effects. Black young adults who are vaccine-resistant or vaccine-neutral may experience larger gains from a digital vaccine intervention. Future work aimed at improving vaccination outcomes could target these populations to maximize resource efficiency and drive the greatest improvements in vaccine outcomes.
- 16 April 2025
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11 (1) , e67370
Open AccessGreater Improvements in Vaccination Outcomes Among Black Young Adults With Vaccine-Resistant Attitudes in the United States South Following a Digital Health Intervention: Latent Profile Analysis of a Randomized Control Trial
Background: Negative attitudes toward vaccines and suboptimal vaccination rates among African American and Black (Black) Americans have been well documented, due to a history of medical racism and human rights violations in the United States. However, digital health interventions (DHI) have been shown to address racial disparities in several health outcomes, such as cardiovascular disease, HIV, and maternal health. The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults in the United States South to make informed, autonomous decisions about COVID-19 vaccine uptake by addressing structural barriers and misinformation about vaccines. Objective: Our objective was to identify subgroups of Black young adults with various vaccine attitudes at baseline and determine the subgroups for which the TT-C DHI was most impactful. Methods: Black young adults aged 18‐29 years in Alabama, Georgia, and North Carolina who were unvaccinated or insufficiently vaccinated against COVID-19 completed three online surveys over three months (N=360). Latent profile analysis was used to identify subgroups based on general vaccine attitudes at baseline, including hesitancy, confidence, knowledge, conspiracy beliefs, and mistrust. Logistic regression was used to examine the associations between latent profiles and vaccine uptake, and linear regression was used to examine changes in vaccine attitudes at three months post-randomization. Modification of the TT-C DHI’s effects was assessed by latent profiles. Results: Three latent profiles emerged: vaccine-receptive (n=124), vaccine-neutral (n=155), and vaccine-resistant (n=81). Political affiliation, income, social support, and recent flu vaccination differed significantly between the three subgroups (P<.05). Vaccine uptake was not significantly different by subgroup, and the TTC-DHI did not have differing effects on uptake across subgroups. However, the DHI had the strongest effect—with statistically significant measures of association (P<.05) and interaction P values (P<.10)—among the baseline vaccine-resistant and vaccine-neutral subgroups compared to the vaccine-receptive subgroups at three months in improving vaccine hesitancy, confidence, and conspiracy beliefs at three months: vaccine-resistant difference: −0.40 (−0.76 to −0.37), 0.39 (0.02 to 0.75), and −0.47 (−0.86 to −0.09); vaccine neutral difference: −0.36 (−0.52 to −0.19), 0.35 (0.18 to 0.51), and −0.24 (−0.44 to −0.03). The DHI had no effects on these outcomes among the vaccine-receptive subgroup. Conclusions: Our findings revealed subgroups of Black young adults in the United States South with different vaccination attitudes, for which the TT-C intervention had differing effects. Black young adults who are vaccine-resistant or vaccine-neutral may experience larger gains from a digital vaccine intervention. Future work aimed at improving vaccination outcomes could target these populations to maximize resource efficiency and drive the greatest improvements in vaccine outcomes.
- 17 March 2025
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 13 (3) , 1898-1909
Relationships Between Vaccine Knowledge, Hesitancy, and Conspiracy Beliefs on COVID-19, Influenza, and HPV Vaccination
Introduction The COVID-19 pandemic highlighted the centuries old issue of vaccine hesitancy and exposed healthcare inequities harming Black young adults. Despite vaccines being able to reduce COVID-19, human papillomavirus (HPV), and influenza morbidity and mortality, they are underutilized. An examination of socio-behavioral factors to understand motivators and barriers to vaccine uptake within Black communities is necessary to improve preventative health. Methods We conducted an online survey of 360 Black young adults, aged 18 and 29 years in the southern United States. Participants were part of a larger randomized-controlled trial which evaluated a digital health intervention for receiving the COVID-19 vaccine. A correlation analysis and a series of logistic regressions were performed to examine the relationships between vaccination knowledge, hesitancy, and conspiracy beliefs for vaccination status for COVID-19, HPV, and influenza. Results Vaccine hesitancy and conspiracy beliefs were negatively associated with COVID-19 vaccination (adjusted odds ratio (AOR) = .45, confidence interval (CI) [.284, .722], p < .001; AOR = .37, CI [.217, .628], p < .001, respectively, but vaccination knowledge was not (p = .295). Vaccination hesitancy was negatively associated with ever having accepted HPV vaccination (AOR = .66, CI [.477, 1.56], p = .011). Vaccination hesitancy, conspiracy beliefs, and knowledge were not significantly associated with influenza vaccination. Conclusions Vaccine hesitancy remains a pertinent factor affecting southern Black young adults. Vaccine-related conspiracy beliefs emerged amidst the COVID-19 pandemic and was significant for refusal of the COVID-19 vaccine. Results indicate the need for continued public health efforts to address vaccine hesitancy and conspiracies among southern Black young adults and providing reputable information from trusted sources recognized by this population.
- 17 March 2025
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 13 (3) , 1898-1909
Relationships Between Vaccine Knowledge, Hesitancy, and Conspiracy Beliefs on COVID-19, Influenza, and HPV Vaccination
Introduction The COVID-19 pandemic highlighted the centuries old issue of vaccine hesitancy and exposed healthcare inequities harming Black young adults. Despite vaccines being able to reduce COVID-19, human papillomavirus (HPV), and influenza morbidity and mortality, they are underutilized. An examination of socio-behavioral factors to understand motivators and barriers to vaccine uptake within Black communities is necessary to improve preventative health. Methods We conducted an online survey of 360 Black young adults, aged 18 and 29 years in the southern United States. Participants were part of a larger randomized-controlled trial which evaluated a digital health intervention for receiving the COVID-19 vaccine. A correlation analysis and a series of logistic regressions were performed to examine the relationships between vaccination knowledge, hesitancy, and conspiracy beliefs for vaccination status for COVID-19, HPV, and influenza. Results Vaccine hesitancy and conspiracy beliefs were negatively associated with COVID-19 vaccination (adjusted odds ratio (AOR) = .45, confidence interval (CI) [.284, .722], p < .001; AOR = .37, CI [.217, .628], p < .001, respectively, but vaccination knowledge was not (p = .295). Vaccination hesitancy was negatively associated with ever having accepted HPV vaccination (AOR = .66, CI [.477, 1.56], p = .011). Vaccination hesitancy, conspiracy beliefs, and knowledge were not significantly associated with influenza vaccination. Conclusions Vaccine hesitancy remains a pertinent factor affecting southern Black young adults. Vaccine-related conspiracy beliefs emerged amidst the COVID-19 pandemic and was significant for refusal of the COVID-19 vaccine. Results indicate the need for continued public health efforts to address vaccine hesitancy and conspiracies among southern Black young adults and providing reputable information from trusted sources recognized by this population.
- Open Access
- 15 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Greater improvements in vaccination outcomes from a digital health intervention among Black young adults in the United States South with vaccine-resistant attitudes: A latent profile analysis of a randomized control trial (Preprint)
BACKGROUND Negative attitudes towards vaccines and suboptimal vaccination rates among African American and Black (Black) Americans has been well documented due to a history of medical racism and human rights violations in the United States (US). However, digital health interventions (DHIs) have been shown to address racial disparities in several health outcomes. The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults (YA) in the US South to make informed, autonomous decisions about COVID-19 vaccine uptake by addressing structural barriers and misinformation about vaccines. OBJECTIVE Our objective was to identify subgroups of Black YA with different vaccine attitudes at baseline and determine for which subgroups the TT-C DHI was most impactful. METHODS Black YA aged 18-29 years in Alabama, Georgia, and North Carolina who were unvaccinated or insufficiently vaccinated against COVID-19 completed three online surveys over three months (N=360). Latent profile analysis was used to identify subgroups based on general vaccine attitudes at baseline including hesitancy, confidence, knowledge, conspiracy beliefs, and mistrust. Logistic regression was used to examine the associations between latent profiles and vaccine uptake, and linear regression was used to examine changes in vaccines attitudes at 3 months post-randomization. Modification of the TT-C DHI’s effects were assessed by latent profiles. RESULTS Three latent profiles emerged: vaccine-receptive (n=124), vaccine-neutral (n=155), and vaccine-resistant (n=81). Political affiliation, income, social support, and recent flu vaccination differed significantly between the three subgroups (P<.05). Vaccine uptake was not significantly different by subgroup and the TTC-DHI did not have differing effecting on uptake across subgroups. However, the DHI had the strongest effect – with statistically significant (P<.05) measures of association and interaction P-values (P<.10) – among the vaccine-resistant and vaccine neutral subgroups at baseline compared to the vaccine-receptive subgroups in improving vaccine hesitancy, confidence, and conspiracy beliefs at 3 months [vaccine-resistant diff: -0.40 (-0.76, -0.37), 0.39 (0.02, 0.75), and -0.47 (-0.86, -0.09); vaccine neutral diff: -0.36 (-0.52, -0.19), 0.35 (0.18, 0.51), and -0.24 (-0.44, -0.03)]. The DHI had no effects on these outcomes among the vaccine-receptive subgroup. CONCLUSIONS Our findings revealed subgroups of Black YA in the US South with different vaccination attitudes, for which the TT-C intervention had differing effects. Black YA who are vaccine-resistant or vaccine-neutral may experience larger gains from a digital vaccine intervention. Future work aimed at improving vaccination outcomes could target these populations to maximize resource efficiency and drive the biggest improvements in vaccine outcomes. CLINICALTRIAL ClinicalTrials.gov NCT05490329
- 15 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessGreater improvements in vaccination outcomes from a digital health intervention among Black young adults in the United States South with vaccine-resistant attitudes: A latent profile analysis of a randomized control trial (Preprint)
BACKGROUND Negative attitudes towards vaccines and suboptimal vaccination rates among African American and Black (Black) Americans has been well documented due to a history of medical racism and human rights violations in the United States (US). However, digital health interventions (DHIs) have been shown to address racial disparities in several health outcomes. The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults (YA) in the US South to make informed, autonomous decisions about COVID-19 vaccine uptake by addressing structural barriers and misinformation about vaccines. OBJECTIVE Our objective was to identify subgroups of Black YA with different vaccine attitudes at baseline and determine for which subgroups the TT-C DHI was most impactful. METHODS Black YA aged 18-29 years in Alabama, Georgia, and North Carolina who were unvaccinated or insufficiently vaccinated against COVID-19 completed three online surveys over three months (N=360). Latent profile analysis was used to identify subgroups based on general vaccine attitudes at baseline including hesitancy, confidence, knowledge, conspiracy beliefs, and mistrust. Logistic regression was used to examine the associations between latent profiles and vaccine uptake, and linear regression was used to examine changes in vaccines attitudes at 3 months post-randomization. Modification of the TT-C DHI’s effects were assessed by latent profiles. RESULTS Three latent profiles emerged: vaccine-receptive (n=124), vaccine-neutral (n=155), and vaccine-resistant (n=81). Political affiliation, income, social support, and recent flu vaccination differed significantly between the three subgroups (P<.05). Vaccine uptake was not significantly different by subgroup and the TTC-DHI did not have differing effecting on uptake across subgroups. However, the DHI had the strongest effect – with statistically significant (P<.05) measures of association and interaction P-values (P<.10) – among the vaccine-resistant and vaccine neutral subgroups at baseline compared to the vaccine-receptive subgroups in improving vaccine hesitancy, confidence, and conspiracy beliefs at 3 months [vaccine-resistant diff: -0.40 (-0.76, -0.37), 0.39 (0.02, 0.75), and -0.47 (-0.86, -0.09); vaccine neutral diff: -0.36 (-0.52, -0.19), 0.35 (0.18, 0.51), and -0.24 (-0.44, -0.03)]. The DHI had no effects on these outcomes among the vaccine-receptive subgroup. CONCLUSIONS Our findings revealed subgroups of Black YA in the US South with different vaccination attitudes, for which the TT-C intervention had differing effects. Black YA who are vaccine-resistant or vaccine-neutral may experience larger gains from a digital vaccine intervention. Future work aimed at improving vaccination outcomes could target these populations to maximize resource efficiency and drive the biggest improvements in vaccine outcomes. CLINICALTRIAL ClinicalTrials.gov NCT05490329
- 1 July 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (10) , 3283-3299
Barriers, Facilitators and Opportunities for HIV Status Disclosure Among Young Men Who Have Sex With Men: Qualitative Findings from the Tough Talks Intervention
Disclosing one’s HIV status can involve complex individual and interpersonal processes interacting with discriminatory societal norms and institutionalized biases. To support disclosure decision-making among young men who have sex with men (YMSM) living with HIV, we developed Tough Talks™, an mHealth intervention that uses artificially intelligent-facilitated role-playing disclosure scenarios and informational activities that build disclosure skills and self-efficacy. Qualitative interviews were conducted with 30 YMSM living with HIV (mean age 24 years, 50% Black) who were enrolled in a randomized controlled trial assessing Tough Talks™ to understand their experiences with HIV status disclosure. Interviews were recorded, transcribed, and thematically coded. Barriers to disclosure focused on fear, anxiety, stigma, and trauma. Facilitators to disclosure are described in the context of these barriers including how participants built comfort and confidence in disclosure decisions and ways the Tough Talks™ intervention helped them. Participants’ narratives identified meaning-making within disclosure conversations including opportunities for educating others and advocacy. Findings revealed ongoing challenges to HIV status disclosure among YMSM and a need for clinical providers and others to support disclosure decision-making and affirm individuals’ autonomy over their decisions to disclose. Considering disclosure as a process rather than discrete events could inform future intervention approaches.
- 1 July 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (10) , 3283-3299
Barriers, Facilitators and Opportunities for HIV Status Disclosure Among Young Men Who Have Sex With Men: Qualitative Findings from the Tough Talks Intervention
Disclosing one’s HIV status can involve complex individual and interpersonal processes interacting with discriminatory societal norms and institutionalized biases. To support disclosure decision-making among young men who have sex with men (YMSM) living with HIV, we developed Tough Talks™, an mHealth intervention that uses artificially intelligent-facilitated role-playing disclosure scenarios and informational activities that build disclosure skills and self-efficacy. Qualitative interviews were conducted with 30 YMSM living with HIV (mean age 24 years, 50% Black) who were enrolled in a randomized controlled trial assessing Tough Talks™ to understand their experiences with HIV status disclosure. Interviews were recorded, transcribed, and thematically coded. Barriers to disclosure focused on fear, anxiety, stigma, and trauma. Facilitators to disclosure are described in the context of these barriers including how participants built comfort and confidence in disclosure decisions and ways the Tough Talks™ intervention helped them. Participants’ narratives identified meaning-making within disclosure conversations including opportunities for educating others and advocacy. Findings revealed ongoing challenges to HIV status disclosure among YMSM and a need for clinical providers and others to support disclosure decision-making and affirm individuals’ autonomy over their decisions to disclose. Considering disclosure as a process rather than discrete events could inform future intervention approaches.
- 28 June 2023
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 52 (6) , 603-624
Virtual reality (VR) treatments for anxiety disorders are unambiguously successful, so why are so few therapists using it? Barriers to adoption and potential solutions
Anxiety disorders are a significant cause of disability globally, yet only one in ten sufferers receives adequate quality treatment. Exposure-based therapies are effective in reducing symptoms associated with a number of anxiety disorders. However, few therapists use exposure techniques to treat these conditions, even when they are adequately trained in them, often because of concerns about provoking distress, drop out, logistical barriers, and other concerns. Virtual reality exposure therapy (VRET) can address many of these concerns, and a large body of research decisively shows that VRET is as efficacious for treating these conditions as in vivo exposures. Yet, use of VRET remains low. In this article, we discuss several factors we believe are contributing to low VRET adoption among therapists and raise potential solutions to address them. We consider steps that VR experience developers and researchers might take, such as leading studies of VRET's real-world effectiveness and treatment optimization trials and continuing to improve the fit of platforms with clinicians' workflows. We also discuss steps to address therapist reservations using aligned implementation strategies, as well as barriers for clinics, and the roles that professional organizations and payers could have in improving care by encouraging adoption of VRET.
- 28 June 2023
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 52 (6) , 603-624
Virtual reality (VR) treatments for anxiety disorders are unambiguously successful, so why are so few therapists using it? Barriers to adoption and potential solutions
Anxiety disorders are a significant cause of disability globally, yet only one in ten sufferers receives adequate quality treatment. Exposure-based therapies are effective in reducing symptoms associated with a number of anxiety disorders. However, few therapists use exposure techniques to treat these conditions, even when they are adequately trained in them, often because of concerns about provoking distress, drop out, logistical barriers, and other concerns. Virtual reality exposure therapy (VRET) can address many of these concerns, and a large body of research decisively shows that VRET is as efficacious for treating these conditions as in vivo exposures. Yet, use of VRET remains low. In this article, we discuss several factors we believe are contributing to low VRET adoption among therapists and raise potential solutions to address them. We consider steps that VR experience developers and researchers might take, such as leading studies of VRET's real-world effectiveness and treatment optimization trials and continuing to improve the fit of platforms with clinicians' workflows. We also discuss steps to address therapist reservations using aligned implementation strategies, as well as barriers for clinics, and the roles that professional organizations and payers could have in improving care by encouraging adoption of VRET.
- Open Access
- 13 February 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e41240
Tough Talks COVID-19 Digital Health Intervention for Vaccine Hesitancy Among Black Young Adults: Protocol for a Hybrid Type 1 Effectiveness Implementation Randomized Controlled Trial
Background: Interventions for increasing the uptake of COVID-19 vaccination among Black young adults are central to ending the pandemic. Black young adults experience harms from structural forces, such as racism and stigma, that reduce receptivity to traditional public health messaging due to skepticism and distrust. As such, Black young adults continue to represent a priority population on which to focus efforts for promoting COVID-19 vaccine uptake. Objective: In aims 1 and 2, the Tough Talks digital health intervention for HIV disclosure will be adapted to address COVID-19 vaccine hesitancy and tailored to the experiences of Black young adults in the southern United States (Tough Talks for COVID-19). In aim 3, the newly adapted Tough Talks for COVID-19 digital health intervention will be tested across the following three southern states: Alabama, Georgia, and North Carolina. Methods: Our innovative digital health intervention study will include qualitative and quantitative assessments. A unique combination of methodological techniques, including web-based surveys, choose-your-own-adventures, digital storytelling, user acceptability testing, and community-based participatory approaches, will culminate in a 2-arm hybrid type 1 effectiveness implementation randomized controlled trial, wherein participants will be randomized to the Tough Talks for COVID-19 intervention arm or a standard-of-care control condition (N=360). Logistic regression will be used to determine the effect of the treatment arm on the probability of vaccination uptake (primary COVID-19 vaccine series or recommended boosters). Concurrently, the inner and outer contexts of implementation will be ascertained and catalogued to inform future scale-up. Florida State University’s institutional review board approved the study (STUDY00003617). Results: Our study was funded at the end of April 2021. Aim 1 data collection concluded in early 2022. The entire study is expected to conclude in January 2025. Conclusions: If effective, our digital health intervention will be poised for broad, rapid dissemination to reduce COVID-19 mortality among unvaccinated Black young adults in the southern United States. Our findings will have the potential to inform efforts that seek to address medical mistrust through participatory approaches. The lessons learned from the conduct of our study could be instrumental in improving health care engagement among Black young adults for several critical areas that disproportionately harm this community, such as tobacco control and diabetes prevention. Trial Registration: ClinicalTrials.gov NCT05490329; https://clinicaltrials.gov/ct2/show/NCT05490329 International Registered Report Identifier (IRRID): DERR1-10.2196/41240
- 13 February 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e41240
Open AccessTough Talks COVID-19 Digital Health Intervention for Vaccine Hesitancy Among Black Young Adults: Protocol for a Hybrid Type 1 Effectiveness Implementation Randomized Controlled Trial
Background: Interventions for increasing the uptake of COVID-19 vaccination among Black young adults are central to ending the pandemic. Black young adults experience harms from structural forces, such as racism and stigma, that reduce receptivity to traditional public health messaging due to skepticism and distrust. As such, Black young adults continue to represent a priority population on which to focus efforts for promoting COVID-19 vaccine uptake. Objective: In aims 1 and 2, the Tough Talks digital health intervention for HIV disclosure will be adapted to address COVID-19 vaccine hesitancy and tailored to the experiences of Black young adults in the southern United States (Tough Talks for COVID-19). In aim 3, the newly adapted Tough Talks for COVID-19 digital health intervention will be tested across the following three southern states: Alabama, Georgia, and North Carolina. Methods: Our innovative digital health intervention study will include qualitative and quantitative assessments. A unique combination of methodological techniques, including web-based surveys, choose-your-own-adventures, digital storytelling, user acceptability testing, and community-based participatory approaches, will culminate in a 2-arm hybrid type 1 effectiveness implementation randomized controlled trial, wherein participants will be randomized to the Tough Talks for COVID-19 intervention arm or a standard-of-care control condition (N=360). Logistic regression will be used to determine the effect of the treatment arm on the probability of vaccination uptake (primary COVID-19 vaccine series or recommended boosters). Concurrently, the inner and outer contexts of implementation will be ascertained and catalogued to inform future scale-up. Florida State University’s institutional review board approved the study (STUDY00003617). Results: Our study was funded at the end of April 2021. Aim 1 data collection concluded in early 2022. The entire study is expected to conclude in January 2025. Conclusions: If effective, our digital health intervention will be poised for broad, rapid dissemination to reduce COVID-19 mortality among unvaccinated Black young adults in the southern United States. Our findings will have the potential to inform efforts that seek to address medical mistrust through participatory approaches. The lessons learned from the conduct of our study could be instrumental in improving health care engagement among Black young adults for several critical areas that disproportionately harm this community, such as tobacco control and diabetes prevention. Trial Registration: ClinicalTrials.gov NCT05490329; https://clinicaltrials.gov/ct2/show/NCT05490329 International Registered Report Identifier (IRRID): DERR1-10.2196/41240
- Open Access
- 8 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e38354
Tough Talks Virtual Simulation HIV Disclosure Intervention for Young Men Who Have Sex With Men: Development and Usability Testing
Background: HIV status disclosure is an important decision with barriers specific to young men who have sex with men (YMSM), who have the highest rates of new HIV infections in the United States. Behavioral and social determinants of the difficulty to disclose can include fear of rejection, stigma, loss of financial stability, and lack of communication skills. Once able to disclose, a person may have increased access to social support and improved informed risk reduction conversations and medication adherence. Despite the known challenges and advantages of disclosure, there are few effective tools supporting this behavior. Objective: To address this gap in disclosure interventions, the Tough Talks (TT) app, an mHealth intervention using artificial intelligence (AI)–facilitated role-playing scenarios, was developed for YMSM. This paper reports stages of development of the integrated app and results of the usability testing. Methods: Building on the successful development and testing of a stand-alone interactive dialogue feature in phases 1-3, we conducted additional formative research to further refine and enhance the disclosure scenarios and develop and situate them within the context of a comprehensive intervention app to support disclosure. We assessed the new iteration for acceptability and relevance in a usability study with 8 YMSM with HIV. Participants completed a presurvey, app modules, and a semistructured qualitative interview. Results: TT content and activities were based on social cognitive theory and disclosure process model framework and expanded to a 4-module curriculum. The AI-facilitated scenarios used dialogue from an utterance database developed using language crowdsourced through a comic book contest. In usability testing, YMSM reported high satisfaction with TT, with 98% (31/33) of activities receiving positive ratings. Participants found the AI-facilitated scenarios and activities to be representative and relevant to their lived experiences, although they noted difficulty having nuanced disclosure conversations with the AI. Conclusions: TT was an engaging and practical intervention for self-disclosure among YMSM with HIV. Facilitating informed disclosure decisions has the potential to impact engagement in sexual risk behaviors and HIV care. More information is needed about the ideal environment, technical assistance, and clinical support for an mHealth disclosure intervention. TT is being tested as a scalable intervention in a multisite randomized controlled trial to address outstanding questions on accessibility and effect on viral suppression. Trial Registration: ClinicalTrials.gov NCT03414372; https://clinicaltrials.gov/ct2/show/NCT03414372
- 8 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e38354
Open AccessTough Talks Virtual Simulation HIV Disclosure Intervention for Young Men Who Have Sex With Men: Development and Usability Testing
Background: HIV status disclosure is an important decision with barriers specific to young men who have sex with men (YMSM), who have the highest rates of new HIV infections in the United States. Behavioral and social determinants of the difficulty to disclose can include fear of rejection, stigma, loss of financial stability, and lack of communication skills. Once able to disclose, a person may have increased access to social support and improved informed risk reduction conversations and medication adherence. Despite the known challenges and advantages of disclosure, there are few effective tools supporting this behavior. Objective: To address this gap in disclosure interventions, the Tough Talks (TT) app, an mHealth intervention using artificial intelligence (AI)–facilitated role-playing scenarios, was developed for YMSM. This paper reports stages of development of the integrated app and results of the usability testing. Methods: Building on the successful development and testing of a stand-alone interactive dialogue feature in phases 1-3, we conducted additional formative research to further refine and enhance the disclosure scenarios and develop and situate them within the context of a comprehensive intervention app to support disclosure. We assessed the new iteration for acceptability and relevance in a usability study with 8 YMSM with HIV. Participants completed a presurvey, app modules, and a semistructured qualitative interview. Results: TT content and activities were based on social cognitive theory and disclosure process model framework and expanded to a 4-module curriculum. The AI-facilitated scenarios used dialogue from an utterance database developed using language crowdsourced through a comic book contest. In usability testing, YMSM reported high satisfaction with TT, with 98% (31/33) of activities receiving positive ratings. Participants found the AI-facilitated scenarios and activities to be representative and relevant to their lived experiences, although they noted difficulty having nuanced disclosure conversations with the AI. Conclusions: TT was an engaging and practical intervention for self-disclosure among YMSM with HIV. Facilitating informed disclosure decisions has the potential to impact engagement in sexual risk behaviors and HIV care. More information is needed about the ideal environment, technical assistance, and clinical support for an mHealth disclosure intervention. TT is being tested as a scalable intervention in a multisite randomized controlled trial to address outstanding questions on accessibility and effect on viral suppression. Trial Registration: ClinicalTrials.gov NCT03414372; https://clinicaltrials.gov/ct2/show/NCT03414372